Sight-Threatening Abnormalities in Newborns Linked to Zika Virus

The rapid spread of the Zika virus infection across South America, and the associated increase in the prevalence of microcephaly, carries with it a host of sight-threatening complications, according to a study recently published in JAMA Ophthalmology.

Researchers at Roberto Santos General Hospital in Salvador, Brazil, found a high rate of ocular abnormalities in newborns with microcephaly associated with congenital Zika virus infection. Of 29 infants with microcephaly examined, ocular lesions were found in 10, many with focal pigment mottling of the retina and chorioretinal atrophy. Optical nerve abnormalities were found in 4 patients.

“This study can help guide clinical management and practice, as we observed that a high proportion of the infants with microcephaly had ophthalmologic lesions. Infants with microcephaly should undergo routine ophthalmologic evaluations to identify such lesions. In high-transmission settings, such as South America, Central America and the Caribbean, ophthalmologists should be aware of the risk of congenital ZIKV-associated ophthalmologic sequelae,” the authors write.

Link to full article: http://archopht.jamanetwork.com/article.aspx?articleid=2491896

 

Featured Posts

Transitions Announces Canadian Consumer Media Campaign for 2023

Campaign features TV along with Spotify and YouTube among a variety of digital activations, as well as a continued partnership with Golf Canada including an educational, on-site activation

Learn More

opti Team Presents Concept and Content for 2024

Strategic expansion of the event and networking with industry and ophthalmic optics: opti is back!

Read more

Wearing Sunglasses Year-round Is Crucial to Maintain Optimal Eye Health

Regular sunglass use reduces exposure to UV rays and the risk of developing cataracts later in life

Read more

Azur by Morel

Designed for the cosmopolitan man, this model, from the Glacier concept, reflects the amalgam of a sporty style to an urban look.

Read more

Testing Two New Therapies to Restore Sight in Advanced Retinitis Pigmentosa

Kiora Pharmaceuticals has announced that they have dosed the first patient in a Phase 1 clinical trial for the photoswitch molecule KIO-301.

Read more

Transitions Announces Canadian Consumer Media Campaign for 2023

Campaign features TV along with Spotify and YouTube among a variety of digital activations, as well as a continued partnership with Golf Canada including an educational, on-site activation

Learn More

opti Team Presents Concept and Content for 2024

Strategic expansion of the event and networking with industry and ophthalmic optics: opti is back!

Read More

Wearing Sunglasses Year-round Is Crucial to Maintain Optimal Eye Health

Regular sunglass use reduces exposure to UV rays and the risk of developing cataracts later in life

Read More

Azur by Morel

Designed for the cosmopolitan man, this model, from the Glacier concept, reflects the amalgam of a sporty style to an urban look.

Read More

Testing Two New Therapies to Restore Sight in Advanced Retinitis Pigmentosa

Kiora Pharmaceuticals has announced that they have dosed the first patient in a Phase 1 clinical trial for the photoswitch molecule KIO-301.

Read More

Transitions Announces Canadian Consumer Media Campaign for 2023

Campaign features TV along with Spotify and YouTube among a variety of digital activations, as well as a continued partnership with Golf Canada including an educational, on-site activation

Learn More

opti Team Presents Concept and Content for 2024

Strategic expansion of the event and networking with industry and ophthalmic optics: opti is back!

Read more

Wearing Sunglasses Year-round Is Crucial to Maintain Optimal Eye Health

Regular sunglass use reduces exposure to UV rays and the risk of developing cataracts later in life

Read more

Azur by Morel

Designed for the cosmopolitan man, this model, from the Glacier concept, reflects the amalgam of a sporty style to an urban look.

Read more

Testing Two New Therapies to Restore Sight in Advanced Retinitis Pigmentosa

Kiora Pharmaceuticals has announced that they have dosed the first patient in a Phase 1 clinical trial for the photoswitch molecule KIO-301.

Read more

Transitions Announces Canadian Consumer Media Campaign for 2023

Campaign features TV along with Spotify and YouTube among a variety of digital activations, as well as a continued partnership with Golf Canada including an educational, on-site activation

Learn More

opti Team Presents Concept and Content for 2024

Strategic expansion of the event and networking with industry and ophthalmic optics: opti is back!

Read more

Wearing Sunglasses Year-round Is Crucial to Maintain Optimal Eye Health

Regular sunglass use reduces exposure to UV rays and the risk of developing cataracts later in life

Read more

Azur by Morel

Designed for the cosmopolitan man, this model, from the Glacier concept, reflects the amalgam of a sporty style to an urban look.

Read more

Testing Two New Therapies to Restore Sight in Advanced Retinitis Pigmentosa

Kiora Pharmaceuticals has announced that they have dosed the first patient in a Phase 1 clinical trial for the photoswitch molecule KIO-301.

Read more